Press Releases
29 November 2021
Hogan Lovells advised Valneva regarding the signing of an Advanced Purchase Agreement (APA) with the European Commission for its Inactivated Covid-19 Vaccine Candidate , VLA2001.
Awards and Rankings
01 October 2021
Washington, D.C., Houston, 1 October 2021 – Global law firm Hogan Lovells is pleased to announce that partners David Bonser, Maria Wyckoff Boyce, Cristina Rodriguez, and Randy Prebula ...
Press Releases
16 July 2021
Munich, 16 July 2021 – Global law firm Hogan Lovells represents Intellia Therapeutics in the launch of a new autologous and allogeneic universal chimeric antigen receptor (CAR) T-cell...
Press Releases
05 January 2021
LONDON and WASHINGTON, D.C., 5 January 2021 – Global law firm Hogan Lovells today announced that 25 of its people have been promoted to partner effective 1 January across a network of ...
Awards and Rankings
24 September 2020
Hogan Lovells is pleased to announce that it scored three major wins at the LMG Life Sciences eighth annual awards event, including being named Regulatory Firm of the Year for a third...
Awards and Rankings
10 August 2020
The LMG Life Sciences Awards highlight the firms, individuals, and companies behind the most innovative and challenging Life Sciences legal work of the past year, as well as those driving...
Press Releases
31 July 2020
Boston, 31 July 2020 – Global law firm Hogan Lovells announced that Scott Kaplan has joined the firm's Boston office as a regulatory counsel in the Life Sciences and Health Care...
Press Releases
13 February 2020
Washington D.C.,13 February 2020 – Hogan Lovells is pleased to announce that it has been selected for the newly adopted Novartis Preferred Firm Panel 3.0. We have pledged to meet the...
